Surgery Doctors in Batesville, AR Accepting Medicare

6 Surgery doctors found. Showing 1 - 6

Jay Raleigh Jeffrey, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 253 Virginia Dr, Batesville, AR 72501 Phone: 870-569-8179    Fax: 870-569-8109

Dr. Luke Edgecombe, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 501 Virginia Dr Ste A, Batesville, AR 72501 Phone: 870-698-1846    Fax: 870-793-2463

John Sydney Lambert, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3443 Harrison St, Batesville, AR 72501 Phone: 870-793-4445    Fax: 870-698-8844

Dr. David Loren Yarnell, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 501 Virginia Dr, Suite A, Batesville, AR 72501 Phone: 870-698-4842

William Steve Alexander, MD Surgery Medicare: Medicare Enrolled Practice Location: 501 Virginia Dr, Suite A, Batesville, AR 72501 Phone: 870-698-1846    Fax: 870-793-2463

David Lee Posey, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 501 Virginia Drive, Suite A, Batesville, AR 72501 Phone: 870-698-1846    Fax: 870-793-2463

News Archive

Dietary supplement extracted from Amaranthus can increase plasma nitrate, study shows

A new, clinical study confirms that dietary supplementation of nitrate from a natural extract of Amaranthus species nicknamed "red spinach," results in a significant increase in plasma nitrite that ultimately enhances nitric oxide.

Sagent Pharma closes initial public offering of 5,750,000 shares of common stock

Sagent Pharmaceuticals, Inc. today announced that it has closed its previously announced initial public offering of 5,750,000 shares of its common stock at a price to the public of $16.00 per share.

Report shares what women need to know and what women can do

Lung Cancer Alliance hailed today's release of "Out of the Shadows: Women and Lung Cancer," a groundbreaking report issued by the Mary Horrigan Connors Center at Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School.

Norepinephrine and emotional memories

Both extensive psychological research and personal experiences confirm that events that happen during heightened states of emotion such as fear, anger and joy are far more memorable than less dramatic occurrences.

Morphotek announces preliminary data from Phase II trial of farletuzumab

Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).

Read more Medical News

› Verified 6 days ago